Wessel Ganzevoort

ORCID: 0000-0002-7243-2115
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pregnancy and preeclampsia studies
  • Birth, Development, and Health
  • Neonatal Respiratory Health Research
  • Maternal and fetal healthcare
  • Gestational Diabetes Research and Management
  • Assisted Reproductive Technology and Twin Pregnancy
  • Pregnancy and Medication Impact
  • Neonatal and fetal brain pathology
  • Preterm Birth and Chorioamnionitis
  • Delphi Technique in Research
  • Cardiovascular Issues in Pregnancy
  • Blood Coagulation and Thrombosis Mechanisms
  • Maternal and Perinatal Health Interventions
  • Prenatal Screening and Diagnostics
  • Global Maternal and Child Health
  • Venous Thromboembolism Diagnosis and Management
  • Maternal Mental Health During Pregnancy and Postpartum
  • Blood Pressure and Hypertension Studies
  • Congenital Diaphragmatic Hernia Studies
  • Cardiac, Anesthesia and Surgical Outcomes
  • Infant Development and Preterm Care
  • Patient-Provider Communication in Healthcare
  • Ectopic Pregnancy Diagnosis and Management
  • Pediatric Urology and Nephrology Studies
  • Reproductive System and Pregnancy

University of Amsterdam
2016-2025

Amsterdam University Medical Centers
2018-2025

University Medical Center
2025

Flinders Medical Centre
2022

Monash University
2020-2022

Amsterdam UMC Location University of Amsterdam
2012-2021

Radboud University Medical Center
2015-2021

Radboud University Nijmegen
2015-2021

Accreditation Council for Graduate Medical Education
2020

University of Groningen
2015-2020

Objective To determine, by expert consensus, a definition for early and late fetal growth restriction (FGR) through Delphi procedure. Method A survey was conducted among an international panel of experts on FGR. Panel members were provided with 18 literature-based parameters defining FGR asked to rate the importance these diagnosis both 5-point Likert scale. Parameters described as solitary (parameters that are sufficient diagnose FGR, even if all other normal) contributory require abnormal...

10.1002/uog.15884 article EN Ultrasound in Obstetrics and Gynecology 2016-02-25

ABSTRACT Objectives Few data exist for counseling and perinatal management of women after an antenatal diagnosis early‐onset fetal growth restriction. Yet, the consequences preterm delivery its attendant morbidity both mother baby are far reaching. The objective this study was to describe mortality following restriction based on time delivery. Methods We report cohort outcomes a prospective multicenter randomized (Trial Randomized Umbilical Fetal Flow in Europe ( TRUFFLE )) performed 20...

10.1002/uog.13190 article EN Ultrasound in Obstetrics and Gynecology 2013-09-23

To determine whether clinical outcomes differed by occurrence of severe hypertension in the international CHIPS trial (Control Hypertension Pregnancy Study), adjusting for interventions "less tight" (target diastolic blood pressure [dBP] 100 mm Hg) versus "tight" control dBP 85 Hg). In this post-hoc analysis data from 987 women with nonsevere nonproteinuric preexisting or gestational hypertension, mixed effects logistic regression was used to compare following according allocated group and...

10.1161/hypertensionaha.116.07862 article EN cc-by-nc-nd Hypertension 2016-09-13

ABSTRACT Objectives Twin pregnancy complicated by selective fetal growth restriction (sFGR) is associated with increased perinatal mortality and morbidity. Inconsistencies in the diagnostic criteria for sFGR employed existing studies hinder ability to compare or combine their findings. It therefore challenging establish robust evidence‐based management monitoring pathways these pregnancies. The main aim of this study was determine, expert consensus using a Delphi procedure, key features...

10.1002/uog.19013 article EN Ultrasound in Obstetrics and Gynecology 2018-01-24

Severe early onset fetal growth restriction caused by placental dysfunction leads to high rates of perinatal mortality and neonatal morbidity. The phosphodiesterase 5 inhibitor, sildenafil, inhibits cyclic guanosine monophosphate hydrolysis, thereby activating the effects nitric oxide, might improve uteroplacental function subsequent outcomes.

10.1001/jamanetworkopen.2020.5323 article EN cc-by-nc-nd JAMA Network Open 2020-06-17

No therapy exists for fetal growth restriction (FGR) due to poor placental function. Current management centers around timing of delivery, balancing the risks intrauterine demise with those prematurity indicated early birth. Pharmacological intervention improve function may be a way overcome this dilemma. The international Sildenafil TheRapy In Dismal prognosis Early-onset Restriction (STRIDER) Consortium was established in 2011 as group investigators committed exploring effects...

10.1002/uog.19186 article EN Ultrasound in Obstetrics and Gynecology 2018-08-06
Ingrid M. Bistervels Andréa Buchmuller Hanke M.G. Wiegers Fionnuala Ní Áinle Bernard Tardy and 95 more Jennifer Donnelly Peter Verhamme Anne Flem Jacobsen Anette Tarp Hansen Marc Rodger Maria T. DeSancho R.G. Shmakov Nick van Es Martin H. Prins Céline Chauleur Saskia Middeldorp Eline S. van den Akker Mireille N. Bekker Thomas van Bemmel Laurent Bertoletti Julie Blanc Suzanne M. Bleker Aude Bourtembourg-Matras Florence Bretelle B. Byrne Françis Couturaud Pierre Delorme Elise S. Eerenberg Maureen TM Franssen Jens Fuglsang Wessel Ganzevoort François Goffinet Jiska M de Haan-Jebbink Wieteke M. Heidema Monique A Hertzberg Marcel M.C. Hovens Menno V. Huisman Leonie de Jong-Speksnijder Pieter W. Kamphuisen Denis J O'Keeffe Karine Lacut Josje Langenveld M Simone Lunshof Caroline P. Martens A. Merah Emmanuelle Le Moigne Dimitri N.M. Papatsonis Gilles Pernod F. Perrotin Edith Peynaud-Debayle Fabrice Pierre Geneviève Bureau Tiphaïne Raia-Barjat Robbert JP Rijnders Roger Rosario M. Ruivard Jeannot Schmidt Marieke Sueters Thomas Vanassche Marie-Noëlle Varlet Alexandre J. Vivanti Matthieu Y. van der Vlist Lucet F. van der Voet Karlijn C. Vollebregt Johanna I. de Vries Sabina de Weerd Peter E. Westerweel Lia DE Wijnberger Marije ten Wolde Paula F. Ypma Catherine Zuily-Lamy Joost J. Zwart Alexandra Benachi G. Beucher H. Bézanahary Karin Boer Marjon A. de Boer Frantz Bousquet Henk A. Bremer Luc Bressollette Aurélie Brossard C. Chau Brian Cleary Fabienne Comte Thomas Corsini Anne Coustel Barbara Debaveye Raoul Desbrière Cécile Duvillard A. Eckman Jeroen Eikenboom Antoine Élias Laura M. Faber Émile Ferrari Denis Gallot Emilie Gauchotte Ingrid Gaugler Abby E. Geerlings Audrey O'Gorman Vincent Grobost

10.1016/s0140-6736(22)02128-6 article EN The Lancet 2022-10-28

Women with complicated pregnancies often require hospital admission. Telemonitoring at home is a promising alternative that fulfils worldwide need in obstetric health care. Moreover, the COVID-19 pandemic has accelerated transformation to digital The aim of this study was evaluate safety, clinical effectiveness, patient satisfaction, and costs telemonitoring against care pregnancies.

10.1016/s2589-7500(22)00231-x article EN cc-by The Lancet Digital Health 2023-02-22

Objectives Plasma volume expansion may benefit both mother and child in the temporising management of severe early onset hypertensive disorders pregnancy. Design Randomised clinical trial. Setting Two university hospitals Amsterdam, The Netherlands. Population hundred sixteen patients with a gestational age between 24 34 completed weeks pre‐eclampsia, haemolysis, elevated liver enzymes low platelets (HELLP) syndrome or fetal growth restriction (FGR) pregnancy‐induced hypertension, admitted 1...

10.1111/j.1471-0528.2005.00687.x article EN BJOG An International Journal of Obstetrics & Gynaecology 2005-06-29
Coming Soon ...